Product
Buprenorphine/naloxone
Aliases
Suboxone
7 clinical trials
11 indications
Indication
Opioid-use DisorderIndication
Opioid Use DisorderIndication
HIV-1 infectionIndication
Immune ActivationIndication
InflammationIndication
methadoneIndication
BuprenorphineIndication
NaltrexoneIndication
Antiretroviral TherapyIndication
Opioid WithdrawalIndication
Opioid DependenceClinical trial
A Method to Increase Buprenorphine Treatment CapacityStatus: Completed, Estimated PCD: 2021-11-23
Clinical trial
Comparing Rapid Micro-Induction and Standard Induction of Buprenorphine/Naloxone for Treatment of Opioid Use Disorder: A Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2025-01-01
Clinical trial
Evaluating Microdosing in Emergency Departments: A Randomized Controlled Trial Comparing the Effectiveness of Buprenorphine/Naloxone Microdosing vs. Standard Dosing (EMED Study)Status: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
Effects of Mu-opiate Receptor Engagement on Microbial Translocation and Residual Immune Activation in HIV-infected, ART Suppressed Opioid Use Disorder Patients Initiating Medication-assisted TreatmentStatus: Recruiting, Estimated PCD: 2024-06-30
Clinical trial
Efficacy of Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid Use DisorderStatus: Recruiting, Estimated PCD: 2026-06-01
Clinical trial
Evaluating the Pharmacokinetics and Patient Outcomes of Buprenorphine MicrodosingStatus: Recruiting, Estimated PCD: 2024-06-30
Clinical trial
Pilot Study to Look at Feasibility of Testing and Treatment of Combination Fentanyl and Opioid Dependent Individuals With Different Buprenorphine Induction MethodsStatus: Withdrawn, Estimated PCD: 2024-02-22